An experimental oral medication for hard-to-treat hypertension is one step closer to approval. According to Fierce Biotech, drugmaker AstraZeneca released new data from Phase III clinical trials that showed significant reductions in average nighttime blood pressure readings among trial participants compared to a placebo. Elevated nighttime blood pressure is associated with increased risk of heart attack, stroke, and other cardiovascular events.
Related Posts
Healing through books
Any bookworm will tell you that a great book can change your life, but can the right book help with anxiety, depression or trauma? Some psychologists say…
Study: You can boost your thinking in just 10 minutes
Anyone can learn and understand more after just 10 minutes of moderate to vigorous exercise. That is the finding of a University of Western Ontario study…
This is a statue of Constantine
Beware the ides of March! Forget Friday the 13th. Ignore ladders, black cats, broken mirrors, and spilled salt. But remember the ides of March (also known…